ENvue Medical shares rise 15.69% after-hours following appointment of David Johnson as new Chairman of the Board.

ENvue Medical surged 15.69% in after-hours trading following the announcement of David Johnson’s appointment as Chairman of the Board of Directors. The effective date of the change, February 2, 2026, coincided with the after-hours price movement. Mr. Johnson, an independent contractor, will receive $10,000 monthly in compensation. The leadership transition is likely viewed favorably by investors, as it may signal strategic direction or governance improvements, though specific details about Johnson’s background or the rationale for the appointment were not disclosed in the SEC filing. The significant after-hours rally suggests market optimism about the board’s new leadership.